STOCK TITAN

AstroNova (NASDAQ: ALOT) narrows FY26 loss, lifts cash flow and sets 2027 growth targets

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

AstroNova, Inc. reported fiscal 2026 fourth-quarter revenue of $37.5 million, essentially flat year over year, as stronger Product Identification sales offset slightly lower Aerospace revenue. Quarterly gross margin slipped to 30.2%, and the company posted a net loss of $1.1 million, or $(0.15) per share, a much smaller loss than the prior year’s impairment-affected results.

For the full year, revenue was $150.5 million and net loss improved significantly to $2.4 million from $14.5 million, while Adjusted EBITDA rose to $12.7 million with an 8.4% margin. Operating cash flow reached $11.7 million, helping reduce debt to $37.6 million as of January 31, 2026.

Product ID segment revenue grew to $104.2 million, with aftermarket sales around 80% of the segment, while Aerospace delivered $46.3 million of revenue and a 21.1% operating margin. Management highlighted strong Aerospace bookings and backlogs in both segments, and noted that a major Aerospace royalty obligation expiring in the third quarter of fiscal 2027 is expected to add about $2 million to annual gross profit. For fiscal 2027, the company targets mid‑single‑digit revenue growth and higher adjusted EBITDA margin.

Positive

  • Profitability and cash flow improved materially: Fiscal 2026 net loss narrowed to $2.4 million from $14.5 million, Adjusted EBITDA rose to $12.7 million (8.4% margin), and operating cash flow reached $11.7 million.
  • Balance sheet strengthened: Total debt declined to $37.6 million from $46.7 million as of January 31, 2025, supported by improved cash generation.
  • High-quality segment performance and visibility: Product ID revenue grew to $104.2 million with ~80% aftermarket mix, Aerospace delivered a 21.1% operating margin, and both segments reported healthy bookings and backlog.
  • Future margin tailwind identified: Expiration of a major Aerospace royalty obligation in Q3 fiscal 2027 is expected to increase annual gross profit by approximately $2 million starting in Q4 fiscal 2027.

Negative

  • None.

Insights

AstroNova shows early turnaround signs with stronger cash flow, margin repair, and constructive 2027 outlook.

AstroNova delivered flat Q4 revenue at $37.5 million but sharply improved profitability versus last year’s impairment-heavy quarter. Full‑year net loss narrowed to $2.4 million from $14.5 million, and $12.7 million Adjusted EBITDA at a 8.4% margin signals core operations are healthier.

Cash generation stands out: operating cash flow of $11.7 million in fiscal 2026 enabled debt reduction from $46.7 million to $37.6 million. Product ID revenue grew to $104.2 million with a recurring aftermarket mix around 80%, while Aerospace maintained a strong 21.1% operating margin despite modest revenue decline.

Management points to additional upside from a major Aerospace royalty obligation expiring in Q3 fiscal 2027, expected to lift annual gross profit by about $2 million from Q4 fiscal 2027 onward. Combined with guidance for mid‑single‑digit revenue growth and expanded adjusted EBITDA margin in fiscal 2027, the filing portrays a business transitioning from restructuring toward steadier, more profitable growth, although execution on Product ID growth and Aerospace order timing remains crucial.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Q4 2026 Revenue $37.5M Three months ended January 31, 2026
FY 2026 Revenue $150.5M Twelve months ended January 31, 2026
FY 2026 Net Loss $2.4M Improved from $14.5M net loss in fiscal 2025
FY 2026 Adjusted EBITDA $12.7M Adjusted EBITDA margin 8.4% for fiscal 2026
Debt Balance $37.6M Debt as of January 31, 2026, down from $46.7M
Product ID Revenue $104.2M Segment revenue for fiscal 2026
Aerospace Operating Margin 21.1% Aerospace segment operating margin, fiscal 2026
Royalty Benefit $2M Expected annual gross profit uplift after Q3 fiscal 2027 royalty expiry
Adjusted EBITDA financial
"Adjusted EBITDA was $3,306 and Adjusted EBITDA margin was 8.8%."
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Non-GAAP gross profit financial
"Non-GAAP Gross Profit | $ 11,903 | $ 12,289 |"
Non-GAAP gross profit is a way companies measure how much money they make from selling their products or services, excluding some expenses that are usually included in standard calculations. It matters because it can give a clearer picture of the company's core earning ability, helping investors understand its performance without certain accounting adjustments.
book-to-bill ratio financial
"The book-to-bill ratio for the segment was 104% and backlog at the end of fiscal 2026 was $13.5 million."
The book-to-bill ratio compares the value of new orders a company receives to the value of products it ships out or bills for over a certain period. If the ratio is above 1, it means the company is getting more orders than it is completing, which can indicate growth. If it's below 1, it suggests demand is slowing down.
backlog financial
"Backlog at the end of fiscal 2026 was $12.0 million."
A backlog is the amount of work or orders that a company has received but hasn't completed yet. It’s like a restaurant with many dishes to serve; the backlog shows how many orders are still waiting to be finished. It matters because a large backlog can indicate strong demand or potential delays in delivering products or services.
royalty obligation financial
"a major royalty obligation for Aerospace will expire in the third quarter this year that will provide an annualized contribution to gross profit of approximately $2 million"
A royalty obligation is a legal promise to pay a continuing fee—often a percentage of sales or a fixed amount—for the right to use someone else’s asset, such as a patent, trademark, mineral rights, or technology. Think of it like paying rent for a tool or recipe: it reduces the owner’s available profits and creates an ongoing cash outflow that can affect a company’s earnings, valuation, and risk profile, so investors watch them to gauge future cash flow and profitability.
segment operating income financial
"Aerospace segment operating profit was $2.3 million, up $0.5 million, or 24.0%"
Segment operating income is the profit a company earns from one specific part of its business after subtracting the costs of running that part but before interest, taxes and corporate-level items. For investors, it shows which divisions are actually generating operating profit and lets you compare the health and efficiency of different business “slices,” much like checking the cash a single store in a chain makes before company-wide overhead is applied.
Revenue $150.5M -0.5% YoY
Net Income (Loss) ($2.4M) improved from ($14.5M)
Adjusted EBITDA $12.7M slightly up from $12.3M
Q4 Revenue $37.5M +0.5% YoY
Guidance

For fiscal 2027, management expects mid-single digit revenue growth and expanded adjusted EBITDA margin.

false 0000008146 0000008146 2026-04-13 2026-04-13
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported): April 13, 2026

 

 

ASTRONOVA, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Rhode Island   0-13200   05-0318215

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

600 East Greenwich Avenue

West Warwick, RI 02893

(Address of principal executive offices) (Zip Code)

(401) 828-4000

Registrant’s telephone number, including area code

Not applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading
Symbol(s)

 

Name of Each Exchange
on which Registered

Common Stock, $0.05 Par Value   ALOT   NASDAQ Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 2.02

Results of Operations and Financial Condition.

On April 13, 2026, we issued a press release reporting the financial results for our fiscal fourth quarter and full year ended January 31, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information contained in Item 2.02 of this report and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 9.01

Financial Statement and Exhibits.

 

(d)

Exhibits

 

Exhibit
No.

  

Exhibit

99.1    Press Release dated April 13, 2026
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ASTRONOVA, INC.
Dated: April 14, 2026     By:  

/s/ Thomas D. DeByle

      Thomas D. DeByle
      Vice President, Chief Financial Officer and Treasurer

Exhibit 99.1

 

LOGO

 

  

News Release

 

 

FOR IMMEDIATE RELEASE

AstroNova Reports Fourth-Quarter and Full-Year

Fiscal 2026 Financial Results

 

   

Fourth quarter revenue of $37.5 million and fiscal 2026 revenue of $150.5 million, in line with guidance

 

   

Fourth quarter net loss was $1.1 million, or $0.15 per diluted share; adjusted EBITDA1 was $3.3 million, or 8.8% of sales

 

   

Product Identification turnaround gaining momentum with well-defined go-to-market and operations strategies

 

   

Total orders in the quarter were up 6.5% to $41.1 million

 

   

Generated $3.7 million of operating cash in the quarter and $11.7 million for the full year, compared with $2.5 million and $4.8 million in the prior periods, respectively

 

   

Strengthened balance sheet with debt reduced by $2.7 million in the quarter and $9.1 million in fiscal 2026

 

   

Previously announced evaluation of strategic alternatives

West Warwick, R.I., April 13, 2026AstroNova, Inc. (Nasdaq: ALOT), a leading innovator in specialized print technology solutions, today announced financial results for its fiscal 2026 fourth quarter and full-year ended January 31, 2026.

Jorik Ittmann, President and Chief Executive Officer of AstroNova, stated, “The second half of fiscal 2026 was a reset period for AstroNova. As we began the year, we recognized that the changes we were making in the business would begin to be realized with a stronger second half. Our focus was on stabilizing the business and ending the year having generated more cash, reduced debt, and raised accountability across both segments. Our Aerospace business delivered a strong performance, with ToughWriter now representing more than 80% of total flight deck printer shipments, positioning us well as aircraft build rates increase.

“In Product ID, we provide label printing solutions that address the needs of three key verticals: healthcare/life sciences, industrial and chemical industries. In these markets our labels are a component of customers’ products and are critical to their success. Our restructuring efforts are being realized through improving commercial momentum in these verticals. We have employed more robust analytics to understand our customers and markets and are better directing our resources to drive growth. This includes continuing to evolve the team, putting the right talent in the correct roles, and recognizing where and why we can win. We expect this focus of our resources where we have competitive advantages will lead to stronger, more profitable growth.”

 
1 

Non-GAAP gross profit, Non-GAAP gross profit margin, Non-GAAP operating income, Non-GAAP operating income margin, Non-GAAP net income, adjusted EBITDA and adjusted EBITDA margin are Non-GAAP financial measures. Refer to the reconciliation of GAAP to non-GAAP measures in the tables that accompany this news release.

-MORE-

 

AstroNova Inc. | 600 East Greenwich Avenue | West Warwick, RI 02893 | 401.828.4000


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 2 of 19

 

Mr. Ittmann added, “Looking ahead to fiscal 2027, we expect Aerospace to deliver measured growth, supported by rising aircraft production, a favorable product mix, and the expiration of a major royalty obligation during the third quarter of the year that negatively impacts gross margin on an annualized basis by approximately $2 million. In Product ID, we are focused on converting our commercial pipeline into consistent revenue growth while strengthening operational performance. We believe we can create greater value for our shareholders with our enhanced product offerings, go-to-market strategy and operational restructuring. Importantly, we will evaluate all strategic alternatives to achieve this goal.”

Fourth Quarter Fiscal 2026 Overview1 (comparisons are to the prior-year period unless noted otherwise)

 

     Three Months Ended     2H Fiscal 2026 compared with 1H Fiscal 2026  
     January 31,
2026
    January 31,
2025
    $
Variance
    %
Variance
    2H FY26     1H FY26     $
Variance
     %
Variance
 

Revenue

   $ 37,536     $ 37,361     $ 175       0.5   $ 76,705     $ 73,810     $ 2,895        3.9

Gross Profit

   $ 11,325     $ 12,226     $ (901     (7.4 )%    $ 24,769     $ 22,865     $ 1,902        8.3

Gross Profit Margin

     30.2     32.7         32.3     31.0     

Non-GAAP Gross Profit

   $ 11,903     $ 12,289     $ (386     (3.1 )%    $ 25,707     $ 23,264     $ 2,444        10.5

Non-GAAP Gross Profit Margin

     31.7     32.9         33.5     31.5     

Operating Income (Loss)

   $ 56     $ (12,311   $ 12,367       (100.5 )%    $ 1,342     $ (137   $ 1,479        N/A  

Operating Margin

     0.1     (33.0 )%          1.7     (0.2 )%      

Non-GAAP Operating Income

   $ 1,124     $ 1,408     $ (284     (20.2 )%    $ 3,688     $ 1,906     $ 1,781        93.4

Non-GAAP Operating Income Margin

     3.0     3.8         4.8     2.6     

Net Income (Loss)

   $ (1,134   $ (15,600   $ 14,466       (92.7 )%    $ (756   $ (1,620   $ 864        53.3

Non-GAAP Net Income (Loss)

   $ (305   $ 419     $ (724     (172.7 )%    $ 1,277     $ (59   $ 1,336        N/A  

Adjusted EBITDA

   $ 3,306     $ 2,794     $ 512       18.3   $ 7,478     $ 5,202     $ 2,276        43.7

Adjusted EBITDA Margin

     8.8     7.5         9.7     7.0     

Compared with the prior-year period, revenue increased $0.2 million as growth in Product ID slightly exceeded lower Aerospace revenue. Tariff mitigation contributed $0.6 million in revenue and foreign currency translation was a $0.8 million benefit in the quarter.

As a result of lower volume and mix, gross profit decreased $0.9 million, or 7.4%, and gross margin contracted 250 basis points compared with the prior-year period. On an adjusted basis, gross margin contracted 120 basis points from the prior-year period to 32.9%.

Operating expenses in the quarter were $11.3 million down from $25.0 million in the prior-year period. The prior year period included a goodwill impairment charge of $13.4 million. Operating income for the quarter was $56 thousand compared with operating loss of $12.3 million in the prior-year period, while non-GAAP operating income was $1.1 million, down $0.3 million compared with the prior-year period.

Interest expense of $0.9 million was nominally unchanged from the prior-year period. Net loss of $1.1 million, or $0.15 per share, compared with net loss of $15.6 million in the prior-year period, which included a goodwill impairment charge of $13.4 million. Non-GAAP net loss was $0.3 million, or $0.04 per share. Adjusted EBITDA was $3.3 million and Adjusted EBITDA margin was 8.8%.

Beginning in the fourth quarter of fiscal 2026, the Company revised its segment reporting methodology to allocate related general and administrative expenses directly to the reportable segments, Product Identification and Aerospace. Management believes this change better reflects the true operating performance of each segment. Prior period segment results have been recast to reflect this change. The impact of this reallocation on segment operating income is presented in the segment tables that follow.


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 3 of 19

 

Product Identification (Product ID) Segment Review

Product ID revenue was $26.3 million for the fourth quarter of fiscal 2026, up 2.5%, or $0.7 million, compared with the prior year. Aftermarket revenue remained strong, representing approximately 80% of total segment sales.

Product ID segment operating loss was $0.2 million, an improvement from the segment operating loss of $13.1 million in the prior-year period which included the previously mentioned goodwill impairment charge. Non-GAAP segment operating loss was $0.1 million, or -0.5% of revenue.

Aerospace Segment Review

Aerospace segment revenue was $11.2 million in the fiscal 2026 fourth quarter, a decrease of 4.1%, or $0.5 million from the prior-year, primarily as a result of the timing of projects.

Despite lower sales, Aerospace segment operating profit was $2.3 million, up $0.5 million, or 24.0%, over the prior-year period as a result of improved mix.

Balance Sheet and Cash Flow

Cash from operations in the fourth quarter of fiscal 2026 was $3.7 million and was $11.7 million year to date. The improvement in cash generation in the quarter was primarily the result of reduced working capital requirements, primarily due to lower inventory.

Capital expenditures in the quarter were $139 thousand and $332 thousand for fiscal 2026 compared with $79 thousand and $1.2 million, respectively, in the prior year.

Cash at the end of the fourth quarter of fiscal 2026 was $4.1 million, down $0.9 million from the end of fiscal 2025. Debt as of January 31, 2026 was $37.6 million compared with $46.7 million as of January 31, 2025.

Bookings and Backlog by Segment

Orders in the quarter for the Product ID segment were $27.5 million, up $2.9 million compared with the prior-year period as the Company’s new go-to-market strategy gained traction. The book-to-bill ratio for the segment was 104% and backlog at the end of fiscal 2026 was $13.5 million.

Orders in the quarter for the Aerospace segment were $13.6 million for a book-to-bill ratio of 122% reflecting demand from OEMs for new-build aircraft. Backlog at the end of fiscal 2026 was $12.0 million.

Fiscal 2027 Outlook

“We are making solid progress with the improvement in our Product ID segment and are delivering on the potential of the Aerospace segment. As noted previously, a major royalty obligation for Aerospace will expire in the third quarter this year that will provide an annualized contribution to gross profit of approximately $2 million beginning in the fourth quarter. We are encouraged with our progress and believe we are creating greater opportunity for the business,” concluded Mr. Ittmann.

For fiscal 2027, AstroNova expects mid-single digit revenue growth and expanded adjusted EBITDA margin.


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 4 of 19

 

Earnings Conference Call Information

AstroNova will host a conference call and webcast at 8:30 a.m. ET on Tuesday, April 14, 2026, to review financial and operating results for the fourth quarter and full year of fiscal 2026. A question and answer session will follow. 

To access the conference call, please dial (201) 689-8560 or find the webcast and accompanying slide presentation at https://investors.astronovainc.com/investors/events-and-presentations/default.aspx.

A telephonic replay will be available from 12:00 p.m. ET on the day of the call through Tuesday, April 28, 2026. To listen to the archived call, dial (412) 317-6671 and enter a replay PIN 13759000. The webcast replay will be available on the Investor Relations section of the Company’s website where a transcript will be posted once available.

About AstroNova, Inc.

AstroNova (Nasdaq: ALOT) is a global provider of printing technologies serving regulated and industrial markets. The Company designs, manufactures, distributes, and services solutions that enable customers to identify, track, and communicate essential product and safety information across a wide range of applications and media. AstroNova supports customers by enabling safety, accuracy and durability for flight deck communications, medical device and healthcare products, essential chemical products, and mission-critical industrial components, while ensuring compliance with local and regional regulatory requirements.

The Product Identification segment delivers end-to-end marking and identification solutions, including hardware, software, and consumables for OEMs, commercial printers, and brand owners. These solutions are used across labels, flexible packaging, corrugated, and industrial substrates, where durability, traceability, and compliance are essential. The Aerospace segment is a global leader in providing products designed for airborne printing solutions, avionics, and data acquisition, including flight deck printing solutions, networking hardware, and specialized aerospace-grade supplies. For more information please visit: www.astronovainc.com.

Use of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this news release contains the Non-GAAP financial measures: Non-GAAP gross profit, Non-GAAP gross profit margin, Non-GAAP operating expenses, Non-GAAP operating income, Non-GAAP operating income margin, Non-GAAP net income (loss), Non-GAAP net income per Common Share - diluted, Non-GAAP segment gross profit, Non-GAAP segment gross profit margin, Non-GAAP segment operating income, Non-GAAP segment operating margin, Adjusted EBITDA and Adjusted EBITDA Margin. AstroNova believes that the inclusion of these Non-GAAP financial measures helps investors gain a meaningful understanding of changes in the Company’s core operating results and can help investors who wish to make comparisons between AstroNova and other companies on both a GAAP and a Non-GAAP basis. AstroNova’s management uses these Non-GAAP financial measures, in addition to GAAP financial measures, as the basis for measuring its core operating performance and comparing such performance to that of prior periods and to the performance of its competitors. These measures are also used by the Company’s management to assist with their financial and operating decision-making. Please refer to the financial reconciliation table included in this news release for a reconciliation of the Non-GAAP measures to the most directly comparable GAAP measures for the three months ended January 31, 2026 and 2025 as well as the years ended January 31, 2026 and 2025.


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 5 of 19

 

Forward-Looking Statements

Information included in this news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact but rather reflect our current expectations concerning future events and results. These statements may include the use of the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning the Company’s anticipated performance, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, (i) the risk that our efforts to improve sales in our Product Identification segment may not result in the benefits we expect, (ii) the risk that our Aerospace customers may not continue to convert to our ToughWriter® printer in the volumes or on the schedule that we expect; (iii) the risk that we may not realize the anticipated benefits of our next-generation print engine technology; and (iv) those factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2025 and subsequent filings AstroNova makes with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The reader is cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this news release.

Contact:

Deborah Pawlowski, IRC, Alliance Advisors

Email: dpawlowski@allianceadvisors.com

Phone: 716.843.3908


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 6 of 19

 

ASTRONOVA, INC.

Condensed Consolidated Statements of Income (Loss)

(In thousands, except per share data)

(Unaudited)

 

     Three Months Ended              
     January 31,
2026
    January 31,
2025
    $ Variance     % Variance  

Revenue

   $ 37,536     $ 37,361     $ 175       0.5

Cost of Revenue

     26,211       25,135       1,076       4.3
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross Profit

     11,325       12,226       (901     (7.4 )% 

Total Gross Profit Margin

     30.2     32.7    

Operating Expenses:

        

Selling & Marketing

     5,642       6,097       (455     (7.5 )% 

Research & Development

     1,797       1,617       180       11.1

General & Administrative

     3,830       3,420       410       12.0

Goodwill Impairment

     —        13,403       (13,403     (100.0 )% 
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Operating Expenses

     11,269       24,537       (13,268     (54.1 )% 

Operating Income (Loss)

     56       (12,311     12,367       (100.5 )% 

Total Operating Margin

     0.1     (33.0 )%     

Interest Expense

     894       847       47       5.5

Other (Income)/Expense, net

     (51     100       (151     (151.0 )% 
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (Loss) Before Taxes

     (788     (13,258     12,470       (94.1 )% 

Income Tax Provision (Benefit)

     346       2,342       (1,996     (85.2 )% 
  

 

 

   

 

 

   

 

 

   

 

 

 

Net Income (Loss)

   $ (1,134   $ (15,600   $ 14,466       (92.7 )% 
  

 

 

   

 

 

   

 

 

   

 

 

 

Net Income (Loss) per Common Share - Basic

   $ (0.15   $ (2.07    
  

 

 

   

 

 

     

Net Income (Loss) per Common Share - Diluted

   $ (0.15   $ (2.07    
  

 

 

   

 

 

     

Weighted Average Number of Common Shares - Basic

     7,653       7,534      

Weighted Average Number of Common Shares - Diluted

     7,653       7,534      

 

     Twelve Months Ended              
     January 31,
2026
    January 31,
2025
    $ Variance     % Variance  

Revenue

   $ 150,515     $ 151,283     $ (768     (0.5 )% 

Cost of Revenue

     102,881       100,625       2,256       2.2
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross Profit

     47,634       50,658       (3,024     (6.0 )% 

Total Gross Profit Margin

     31.6     33.5    

Operating Expenses:

        

Selling & Marketing

     22,963       24,252       (1,289     (5.3 )% 

Research & Development

     6,788       6,047       741       12.3

General & Administrative

     16,380       15,596       784       5.0

Goodwill Impairment

     297       13,403       (13,106     (97.8 )% 
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Operating Expenses

     46,428       59,298       (12,870     (21.7 )% 

Operating Income (Loss)

     1,206       (8,640     9,846       (114.0 )% 

Total Operating Margin

     0.8     (5.7 )%     

Interest Expense

     3,503       3,210       293       9.1

Other (Income)/Expense, net

     239       437       (198     (45.3 )% 
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (Loss) Before Taxes

     (2,536     (12,287     9,751       (79.4 )% 

Income Tax Provision (Benefit)

     (160     2,202       (2,362     (107.3 )% 
  

 

 

   

 

 

   

 

 

   

 

 

 

Net Income (Loss)

   $ (2,376   $ (14,489   $ 12,113       (83.6 )% 
  

 

 

   

 

 

   

 

 

   

 

 

 

Net Income (Loss) per Common Share - Basic

   $ (0.31   $ (1.93    
  

 

 

   

 

 

     

Net Income (Loss) per Common Share - Diluted

   $ (0.31   $ (1.93    
  

 

 

   

 

 

     

Weighted Average Number of Common Shares - Basic

     7,614       7,509      

Weighted Average Number of Common Shares - Diluted

     7,614       7,509      


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 7 of 19

 

ASTRONOVA, INC.

Condensed Consolidated Balance Sheets

(In thousands)

(Unaudited)

 

     January 31,
2026
    January 31,
2025
 

ASSETS

    

CURRENT ASSETS

    

Cash and Cash Equivalents

   $ 4,072     $ 5,050  

Accounts Receivable, net

     18,985       21,218  

Inventories, net

     43,252       47,894  

Prepaid Expenses and Other Current Assets

     4,395       3,855  
  

 

 

   

 

 

 

Total Current Assets

     70,704       78,017  

PROPERTY, PLANT AND EQUIPMENT

     40,400       58,613  

Less Accumulated Depreciation

     (26,272     (42,820
  

 

 

   

 

 

 

Property, Plant and Equipment, net

     14,128       15,793  

OTHER ASSETS

    

Identifiable Intangibles, net

     21,496       23,519  

Goodwill

     17,376       16,361  

Deferred Tax Assets, net

     9,831       8,431  

Right of Use Asset

     2,466       1,781  

Other Assets

     1,565       1,693  
  

 

 

   

 

 

 

TOTAL ASSETS

   $ 137,566     $ 145,595  
  

 

 

   

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

    

CURRENT LIABILITIES

    

Accounts Payable

   $ 6,806     $ 7,928  

Accrued Compensation

     4,390       3,745  

Other Accrued Expenses

     4,702       4,461  

Revolving Line of Credit

     16,273       20,929  

Current Portion of Long-Term Debt

     3,033       6,110  

Short-Term Debt

     —        581  

Current Liability – Royalty Obligation

     1,656       1,358  

Current Liability – Excess Royalty Payment Due

     331       691  

Income Taxes Payable

     691       —   

Deferred Revenue

     489       543  
  

 

 

   

 

 

 

Total Current Liabilities

     38,371       46,346  

NON-CURRENT LIABILITIES

    

Long-Term Debt, net of current portion

     18,295       19,044  

Lease Liabilities, net of current portion

     1,953       1,535  

Grant Deferred Revenue

     899       1,090  

Royalty Obligation, net of current portion

     145       1,106  

Income Tax Payables

     800       684  

Deferred Tax Liabilities

     —        40  

Other Long-Term Liability

     241       —   
  

 

 

   

 

 

 

TOTAL LIABILITIES

     60,704       69,845  

SHAREHOLDERS’ EQUITY

    

Common Stock

     554       547  

Additional Paid-in Capital

     66,329       64,215  

Retained Earnings

     47,004       49,380  

Treasury Stock

     (35,227     (35,043

Accumulated Other Comprehensive Loss, net of tax

     (1,798     (3,349
  

 

 

   

 

 

 

TOTAL SHAREHOLDERS’ EQUITY

     76,862       75,750  
  

 

 

   

 

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

   $ 137,566     $ 145,595  
  

 

 

   

 

 

 


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 8 of 19

 

ASTRONOVA, INC.

Condensed Consolidated Statements of Cash Flow

(In thousands)

(Unaudited)

 

     Three Months Ended  
     January 31, 2026     January 31, 2025  

Cash Flows from Operating Activities:

    

Net Income (Loss)

   $ (1,134   $ (15,599

Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:

    

Depreciation and Amortization

     1,379       1,266  

Grant Income Included in Depreciation

     155       51  

Goodwill Impairment

     —        13,403  

Amortization of Debt Issuance Costs

     10       8  

Share-Based Compensation

     751       219  

Deferred Income Tax Provision (Benefit)

     (1,238     874  

Loss on Disposal of Fixed Assets

     3       —   

Changes in Assets and Liabilities:

    

Accounts Receivable

     1,566       1,240  

Inventories

     2,129       236  

Income Taxes

     1,764       630  

Accounts Payable and Accrued Expenses

     (758     (8

Deferred Revenue

     (519     (440

Other

     (434     645  
  

 

 

   

 

 

 

Net Cash Provided by Operating Activities

   $ 3,673     $ 2,525  

Cash Flows from Investing Activities:

    

Proceeds from Sale of Equipment

     13       —   

Purchases of Property, Plant and Equipment

     (139     (79

Cash Paid for MTEX Acquisition, net of cash acquired

     —        —   
  

 

 

   

 

 

 

Net Cash Used for Investing Activities

   $ (126   $ (79

Cash Flows from Financing Activities:

    

Net Cash Proceeds from Employee Stock Option Plans

     —        —   

Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan

     —        48  

Net Cash Used for Payment of Taxes Related to Vested Restricted Stock

     (1     (18

Revolving Credit Facility, net

     (1,981     734  

Proceeds from Long Term Debt Borrowings

     —        —   

Payment of Minimum Guarantee Royalty Obligation

     (279     (655

Principal Payments of Long-Term Debt

     (864     (2,274

Payments of Debt Issuance Costs

     —        3  
  

 

 

   

 

 

 

Net Cash Provided by (Used for) Financing Activities

   $ (3,125   $ (2,163

Effect of Exchange Rate Changes on Cash and Cash Equivalents

     44       336  
  

 

 

   

 

 

 

Net Increase in Cash and Cash Equivalents

   $ 466     $ 618  

Cash and Cash Equivalents, Beginning of Period

     3,606       4,432  
  

 

 

   

 

 

 

Cash and Cash Equivalents, End of Period

   $ 4,072     $ 5,050  
  

 

 

   

 

 

 

Supplemental Information:

    

Cash Paid During the Period for:

    

Interest

   $ 751     $ 810  

Income Taxes, net of refunds

     13     $ 707  

Non-Cash Transactions:

    

Operating Lease Obtained in Exchange for Operating Lease Liabilities

   $ 89     $ —   


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 9 of 19

 

ASTRONOVA, INC.

Condensed Consolidated Statements of Cash Flow – Twelve Months Ended

(In thousands)

(Unaudited)

 

     Twelve Months Ended  
     January 31, 2026     January 31, 2025  

Cash Flows from Operating Activities:

    

Net Income (Loss)

   $ (2,376   $ (14,489

Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:

    

Depreciation and Amortization

     4,804       4,780  

Grant Income Included in Depreciation

     330       159  

Goodwill Impairment

     297       13,403  

Amortization of Debt Issuance Costs

     43       30  

Share-Based Compensation

     2,310       1,378  

Deferred Income Tax Provision (Benefit)

     (1,312     874  

Loss on Disposal of Fixed Assets

     115       —   

Changes in Assets and Liabilities:

    

Accounts Receivable

     2,786       2,859  

Inventories

     5,909       1,616  

Income Taxes

     663       (904

Accounts Payable and Accrued Expenses

     (1,125     (2,379

Deferred Revenue

     (420     (1,520

Other

     (286     (959
  

 

 

   

 

 

 

Net Cash Provided by Operating Activities

   $ 11,738     $ 4,848  

Cash Flows from Investing Activities:

    

Proceeds from Sale of Equipment

     113       —   

Purchases of Property, Plant and Equipment

     (332     (1,165

Cash Paid for MTEX Acquisition, net of cash acquired

     —        (19,109
  

 

 

   

 

 

 

Net Cash Used for Investing Activities

   $ (219   $ (20,274

Cash Flows from Financing Activities:

    

Net Cash Proceeds from Employee Stock Option Plans

     —        12  

Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan

     51       146  

Net Cash Used for Payment of Taxes Related to Vested Restricted Stock

     (184     (450

Revolving Credit Facility, net

     (5,158     11,508  

Proceeds from Long Term Debt Borrowings

     19,720       15,078  

Payment of Minimum Guarantee Royalty Obligation

     (1,238     (1,902

Principal Payments of Long-Term Debt

     (25,982     (8,980

Payments of Debt Issuance Costs

     (66     (34
  

 

 

   

 

 

 

Net Cash Provided by (Used for) Financing Activities

   $ (12,857   $ 15,378  

Effect of Exchange Rate Changes on Cash and Cash Equivalents

     360       571  
  

 

 

   

 

 

 

Net (Decrease) Increase in Cash and Cash Equivalents

   $ (978   $ 523  

Cash and Cash Equivalents, Beginning of Period

     5,050       4,527  
  

 

 

   

 

 

 

Cash and Cash Equivalents, End of Period

   $ 4,072     $ 5,050  
  

 

 

   

 

 

 

Supplemental Information:

    

Cash Paid During the Period for:

    

Interest

   $ 3,043     $ 2,701  

Income Taxes, net of refunds

     634       2,210  

Non-Cash Transactions:

    

Operating Lease Obtained in Exchange for Operating Lease Liabilities

   $ 1,075     $ 1,581  


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 10 of 19

 

ASTRONOVA, INC.

Segment Sales and Profit

(Unaudited, $ in thousands)

 

     Three Months
Ended
    Twelve Months
Ended
 
($ in thousands)    January 31,
2026
    January 31,
2025
    January 31,
2026
    January 31,
2025
 

Revenue:

        

Product ID

   $ 26,330     $ 25,678     $ 104,221     $ 102,345  

Aerospace

     11,206       11,683       46,294       48,938  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Revenue

   $ 37,536     $ 37,361     $ 150,515     $ 151,283  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross Profit:

        

Product ID

   $ 7,088     $ 8,237     $ 29,837     $ 32,571  

Aerospace

     4,237       3,989       17,797       18,087  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross Profit

   $ 11,325     $ 12,226     $ 47,634     $ 50,658  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross Profit Margin:

        

Product ID

     26.9     32.1     28.6     31.8

Aerospace

     37.8     34.1     38.4     37.0
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross Profit Margin

     30.2     32.7     31.6     33.5
  

 

 

   

 

 

   

 

 

   

 

 

 

Segment Operating Income:

        

Product ID

   $ (234   $ (13,076   $ (472   $ (11,860

Aerospace

     2,337       1,885       9,763       9,087  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Segment Operating Income

   $ 2,103     $ (11,191   $ 9,291     $ (2,773
  

 

 

   

 

 

   

 

 

   

 

 

 

Segment Operating Margin:

        

Product ID

     (0.9 )%      (50.9 )%      (0.5 )%      (11.6 )% 

Aerospace

     20.9     16.1     21.1     18.6
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Segment Operating Margin

     5.6     (30.0 )%      6.2     (1.8 )% 
  

 

 

   

 

 

   

 

 

   

 

 

 

Corporate Expense

     (2,049     (1,120     (8,085     (5,867
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating Income (Loss)

   $ 54     $ (12,311   $ 1,206     $ (8,640

Interest Expense

   $ 894     $ 847     $ 3,503     $ 3,210  

Other (Income)/Expense, net

     (51     100       239       437  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (Loss) Before Income Taxes

   $ (788   $ (13,259   $ (2,536   $ (12,287

Income Tax Provision (Benefit)

     346       2,342       (160     2,202  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net Income (Loss)

   $ (1,134   $ (15,600   $ (2,376   $ (14,489
  

 

 

   

 

 

   

 

 

   

 

 

 


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 11 of 19

 

ASTRONOVA, INC.

Segment Sales and Non-GAAP Profit

(Unaudited, $ in thousands)

 

     Three Months
Ended
    Twelve Months
Ended
 
($ in thousands)    January 31,
2026
    January 31,
2025
    January 31,
2026
    January 31,
2025
 

Revenue:

        

Product ID

   $ 26,330     $ 25,678     $ 104,221     $ 102,345  

Aerospace

     11,206       11,683       46,294       48,938  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Revenue

   $ 37,536     $ 37,361     $ 150,515     $ 151,283  
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Gross Profit:

        

Product ID

   $ 7,356     $ 8,296     $ 31,010     $ 32,770  

Aerospace

     4,547       3,989       17,961       18,087  
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Gross Profit

   $ 11,903     $ 12,285     $ 48,971     $ 50,857  
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Gross Profit Margin:

        

Product ID

     27.9     32.3     29.8     32.0

Aerospace

     40.6     34.1     38.8     37.0
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Gross Profit Margin

     31.7     32.9     32.5     33.6
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Segment Operating Income:

        

Product ID

   $ (124)     $ 647     $ 1,542     $ 2,966  

Aerospace

     2,648       1,886       9,934       9,088  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Non-GAAP Segment Operating Income

   $ 2,524     $ 2,533     $ 11,476     $ 12,054  
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Segment Operating Margin:

        

Product ID

     (0.5)     2.5     1.5     2.9

Aerospace

     23.6     16.1     21.5     18.6
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Non-GAAP Segment Operating Margin

     6.7     6.8     7.6     8.0
  

 

 

   

 

 

   

 

 

   

 

 

 

Corporate Expense

     (1,400)       (1,123)       (5,882)       (5,437)  
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Operating Income

   $ 1,124     $ 1,409     $ 5,594     $ 6,617  

Interest Expense

   $ 894     $ 847     $ 3,503     $ 3,210  

Other (Income)/Expense, net

     (51)       100       28       437  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income Before Income Taxes

   $ 281     $ 462     $ 2,063     $ 2,970  

Adjusted Income Tax Provision (Benefit)

     586       43       845       284  
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Net Income

   $ (305)     $ 419     $ 1,218     $ 2,686  
  

 

 

   

 

 

   

 

 

   

 

 

 


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 12 of 19

 

ASTRONOVA, INC.

Revenue by Market

(unaudited, $ in thousands)

 

Product ID:

   Q1 FY25      Q2 FY25      Q3 FY25      Q4 FY25      FY2025      Q1 FY26      Q2 FY26      Q3 FY26      Q4 FY26      FY2026  

Desktop Label Printers

   $ 14,220      $ 16,349      $ 15,408      $ 14,019      $ 59,996      $ 15,478      $ 15,190      $ 16,115        15,041        61,824  

Mail & Sheet/Flat Pack Printers

     3,930        3,471        3,679        4,494        15,574        4,050        3,740        4,280        4,138        16,208  

Professional Label Printers

     3,245        4,231        3,423        2,972        13,871        3,247        3,506        3,636        3,863        14,252  

Direct to Package/Overprint Printers

     1,787        2,925        3,627        2,718        11,057        3,396        2,230        2,371        2,579        10,576  

Flexible Packaging Printers

     —         —         15        1,289        1,304        30        69        79        38        216  

Other

     3        189        165        186        543        88        19        368        670        1,145  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

TOTAL

   $ 23,185      $ 27,165      $ 26,317      $ 25,678      $ 102,345      $ 26,289      $ 24,754      $ 26,849        26,330        104,221  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Aerospace:

   Q1 FY25      Q2 FY25      Q3 FY25      Q4 FY25      FY2025      Q1 FY26*      Q2 FY26      Q3 FY26      Q4 FY26      FY2026  

Commercial Aircraft

   $ 3,813      $ 6,299      $ 5,221      $ 4,363      $ 19,696      $ 4,953      $ 4,714      $ 5,764      $ 5,030      $ 20,461  

Aftermarket

     4,694        5,326        7,058        5,481        22,559        4,911        4,953        4,955        4,831        19,650  

Defense

     329        608        734        781        2,452        811        1,047        766        885        3,509  

Regional and Biz Jet Aircraft

     697        604        993        802        3,096        396        431        634        195        1,656  

Other

     243        537        99        256        1,135        348        203        201        266        1,018  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

TOTAL

   $ 9,776      $ 13,374      $ 14,105      $ 11,683      $ 48,938      $ 11,419      $ 11,348      $ 12,320      $ 11,206      $ 46,294  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated Total

   $ 32,961      $ 40,539      $ 40,422      $ 37,361      $ 151,283      $ 37,708      $ 36,102      $ 39,169        37,536        150,515  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

*

Q1 fiscal 2026 revenue by market has been revised from amount previously reported in our Q1 fiscal 2026 press release issued on June 5, 2025, to correct a classification error between market categories. Total Q1 fiscal sales were unaffected.

ASTRONOVA, INC.

Revenue by Type

(unaudited, $ in thousands)

 

Product ID

   Q1 FY25      Q2 FY25      Q3 FY25      Q4 FY25      FY 2025      Q1 FY26      Q2 FY26      Q3 FY26      Q4 FY26      FY 2026  

Product ID HW

   $ 3,802      $ 4,311      $ 4,590      $ 5,591      $ 18,294      $ 4,776      $ 4,511      $ 5,357      $ 5,332      $ 19,976  

Product ID Recurring Supplies, Parts & Service

     19,383        22,854        21,727        20,087        84,051        21,513        20,243        21,492        20,997        84,245  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total Product ID

   $ 23,185      $ 27,165      $ 26,317      $ 25,678      $ 102,345      $ 26,289      $ 24,754      $ 26,849      $ 26,330      $ 104,221  

Aerospace

                             

Aerospace HW

   $ 5,073      $ 8,048      $ 7,032      $ 6,185      $ 26,338      $ 6,519      $ 6,425      $ 7,360      $ 6,369      $ 26,673  

Aerospace Recurring Supplies, Parts & Service

     4,703        5,326        7,073        5,498        22,600        4,900        4,923        4,960        4,838        19,621  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total Aerospace

   $ 9,776      $ 13,374      $ 14,105      $ 11,683      $ 48,938      $ 11,419      $ 11,348      $ 12,320      $ 11,206      $ 46,294  

Consolidated

                             

AstroNova HW

   $ 8,875      $ 12,359      $ 11,622      $ 11,776      $ 44,632      $ 11,295      $ 10,936      $ 12,717      $ 11,701      $ 46,649  

AstroNova Recurring Supplies, Parts & Service

     24,086        28,180        28,800        25,585        106,651        26,413        25,166        26,452        25,835        103,866  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

TOTAL

   $ 32,961      $ 40,539      $ 40,422      $ 37,361      $ 151,283      $ 37,708      $ 36,102      $ 39,169      $ 37,536      $ 150,515  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 13 of 19

 

ASTRONOVA, INC.

Bookings and Backlog

(unaudited, $ in thousands)

AstroNova

 

     Q1 FY25     Q2 FY25     Q3 FY25     Q4 FY25     FY 2025     Q1 FY26     Q2 FY26     Q3 FY26     Q4 FY26     FY 2026  

Beginning backlog (Non-MTEX)

   $ 31,394     $ 31,556     $ 29,900     $ 27,093     $ 31,394     $ 28,307     $ 25,491     $ 25,291     $ 21,989     $ 28,307  

MTEX*

   $ —      $ 3,084     $ —      $ —      $ 3,084     $ —      $ —      $ —      $ —      $ —   

Backlog Beginning of Period (incl. MTEX)

   $ 31,394     $ 34,640     $ 29,900     $ 27,093     $ 34,478     $ 28,307     $ 25,491     $ 25,291     $ 21,989     $ 28,307  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Revenue Recognized (Billings)

   $ 32,961     $ 40,539     $ 40,422     $ 37,361     $ 151,283     $ 37,708     $ 36,102     $ 39,169     $ 37,536     $ 150,515  

New Bookings During Period

   $ 33,122     $ 35,799     $ 37,615     $ 38,576     $ 145,112     $ 34,893     $ 35,901     $ 35,867     $ 41,077     $ 147,738  

Backlog End of Period

   $ 31,556     $ 29,900     $ 27,093     $ 28,307     $ 28,307     $ 25,491     $ 25,291     $ 21,989     $ 25,530     $ 25,530  

Book/Bill %

     100     88     93     103     96     93     99     92     109     96

 

*

MTEX Backlog was acquired during 2nd quarter fiscal 2025

Product Identification

 

     Q1 FY25     Q2 FY25     Q3 FY25     Q4 FY25     FY 2025     Q1 FY26     Q2 FY26     Q3 FY26     Q4 FY26     FY 2026  

Beginning backlog (Non-MTEX)

   $ 19,725     $ 19,467     $ 18,786     $ 19,254     $ 19,725     $ 18,091     $ 18,044     $ 16,727     $ 12,351     $ 18,091  

MTEX*

   $ —      $ 3,084     $ —      $ —      $ 3,084     $ —      $ —      $ —      $ —      $ —   

Backlog Beginning of Period (incl. MTEX)

   $ 19,725     $ 22,551     $ 18,786     $ 19,254     $ 22,809     $ 18,091     $ 18,044     $ 16,727     $ 12,351     $ 18,091  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Revenue Recognized (Billings)

   $ 23,185     $ 27,165     $ 26,317     $ 25,678     $ 102,345     $ 26,289     $ 24,754     $ 26,849     $ 26,330     $ 104,221  

New Bookings During Period

   $ 22,926     $ 23,400     $ 26,785     $ 24,516     $ 97,627     $ 26,242     $ 23,437     $ 22,473     $ 27,460     $ 99,612  

Backlog End of Period

   $ 19,467     $ 18,786     $ 19,254     $ 18,091     $ 18,091     $ 18,044     $ 16,727     $ 12,351     $ 13,484     $ 13,482  

Book/Bill %

     99     86     102     95     95     100     95     84     104     95

 

*

MTEX Backlog was acquired during 2nd quarter fiscal 2025

Aerospace

 

     Q1 FY25     Q2 FY25     Q3 FY25     Q4 FY25     FY 2025     Q1 FY26     Q2 FY26     Q3 FY26     Q4 FY26     FY 2025  

Backlog Beginning of Period

   $ 11,669     $ 12,089     $ 11,114     $ 7,839     $ 11,669     $ 10,216     $ 7,447     $ 8,563     $ 9,638     $ 10,216  

Revenue Recognized (Billings)

   $ 9,776     $ 13,374     $ 14,105     $ 11,683     $ 48,938     $ 11,419     $ 11,348     $ 12,320     $ 11,206     $  46,294  

New Bookings During Period

   $ 10,196     $ 12,399     $ 10,830     $ 14,060     $  47,485     $ 8,651     $ 12,464     $ 13,394     $ 13,617     $ 48,126  

Backlog End of Period

   $ 12,089     $ 11,114     $ 7,839     $ 10,216     $ 10,216     $ 7,447     $ 8,563     $ 9,638     $ 12,047     $ 12,048  

Book/Bill %

     104     93     77     120     97     76     110     109     122     97


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 14 of 19

 

ASTRONOVA, INC.

Segment Sales and Profit – Historical Quarterly Summary (Recast)

(unaudited, $ in thousands)

 

         FY24     Q1     Q2     Q3     Q4     FY25     Q1     Q2     Q3     Q4     FY26  

LOGO

                                                                      
  Revenue    $ 44,045       9,776       13,374       14,105       11,683     $ 48,938       11,419       11,348       12,320       11,206     $ 46,294  
  Gross profit    $ 15,900       3,456       5,548       5,093       3,989     $ 18,087       3,719       3,721       6,121       4,236     $ 17,797  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  Gross Profit Margin      36.1     35.4     41.5     36.1     34.1     37.0     32.6     32.8     49.7     37.8     38.4
  Operating Expenses:                       
  Selling & Marketing    $ 3,433       904       899       913       822     $ 3,537       481       911       1,095       772     $ 3,260  
  Research & Development    $ 2,347       801       781       877       785     $ 3,243       652       603       710       656     $ 2,621  
  General & Administrative    $ 1,881       644       567       512       497     $ 2,220       606       540       536       471     $ 2,154  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  Total Operating Expenses    $ 7,661       2,348       2,246       2,301       2,104     $ 9,000       1,739       2,055       2,341       1,899     $ 8,034  
  Aerospace Operating Income    $ 8,240       1,108       3,302       2,792       1,885     $ 9,087       1,980       1,666       3,780       2,338     $ 9,763  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  Aerospace Operating Margin      18.7     11.3     24.7     19.8     16.1     18.6     17.3     14.7     30.7     20.9     21.1
  Non-GAAP                       
  Aerospace Adjusted EBITDA1    $ 10,239       1,519       3,719       3,193       2,279     $ 10,710       2,566       2,081       3,911       3,104     $ 11,662  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  Adjusted EBITDA Margin1      23.2     15.5     27.8     22.6     19.5     21.9     22.5     18.3     31.7     27.7     25.2
         FY24     Q1     Q2     Q3     Q4     FY25     Q1     Q2     Q3     Q4     FY26  

LOGO

                                                                      
  Revenue    $ 104,041       23,185       27,165       26,317       25,679     $ 102,345       26,289       24,754       26,849       26,330     $ 104,221  
  Gross profit    $ 33,604       8,002       8,315       8,015       8,236     $ 32,570       8,232       7,194       7,323       7,088     $ 29,838  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  Gross Profit Margin      32.3     34.5     30.6     30.5     32.1     31.8     31.3     29.1     27.3     26.9     28.6
  Operating Expenses:                       
  Selling & Marketing    $ 19,971       4,436       5,567       5,438       5,274     $ 20,715       5,124       4,935       4,773       4,870     $ 19,703  
  Research & Development    $ 3,994       670       507       795       832     $ 2,804       877       961       1,188       1,141     $ 4,167  
  General & Administrative    $ 4,314       1,447       2,363       1,896       15,206     $ 20,911       1,971       1,490       1,667       1,310     $ 6,439  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  Total Operating Expenses    $ 28,280       6,553       8,437       8,128       21,312     $ 44,430       7,973       7,387       7,628       7,323     $ 30,310  
  Product ID Operating Income    $ 5,325       1,449       (121     (112     (13,076   $ (11,860     259       (192     (304     (234   $ (472
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  Product ID Operating Margin      5.1     6.2     (0.4 )%      (0.4 )%      (50.9 )%      (11.6 )%      1.0     (0.8 )%      (1.1 )%      (0.9 )%      (0.5 )% 
  Non-GAAP                       
  Product ID Adjusted EBITDA1    $ 11,156       2,046       1,619       1,269       1,615     $ 6,550       1,902       870       1,371       1,095     $ 5,238  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  Adjusted EBITDA Margin1      10.7     8.8     6.0     4.8     6.3     6.4     7.2     3.5     5.1     4.2     5.0
  Corporate Expense    $ 4,768       1,211       2,120       1,416       1,120     $ 5,867       1,668       2,181       2,187       2,049     $ 8,086  
                        
 
LOGO   Consolidated Operating Income      8,796       1,346       1,061       1,264       (12,311     (8,640     571       (708     1,288       55       1,206  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  Consolidated Operating Margin      5.9     4.1     2.6     3.1     (33.0 )%      (5.7 )%      1.5     (2.0 )%      3.3     0.1     0.8
  Non-GAAP                       
  Adjusted EBITDA1    $ 17,601       2,463       3,849       3,230       2,793     $ 12,336       3,146       2,056       4,173       3,306     $ 12,681  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  Adjusted EBITDA Margin1      11.9     7.5     9.5     8.0     7.5     8.2     8.3     5.7     10.7     8.8     8.4
                        
(1) 

Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP metrics. Please refer to the reconciliation of GAAP to non-GAAP metrics in the tables that accompany this news release.


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 15 of 19

 

ASTRONOVA, INC.

Reconciliation of GAAP to Non-GAAP Items

(Unaudited, $ in thousands)

 

     Three Months Ended     Twelve Months Ended     2H Fiscal 2026 and 1H Fiscal 2026  
     January 31,
2026
    January 31,
2025
    January 31,
2026
    January 31,
2025
    2H FY26     1H FY26  

Revenue

   $ 37,536     $ 37,361     $ 150,515     $ 151,283     $ 76,705     $ 73,810  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross Profit

   $ 11,324     $ 12,227     $ 47,634     $ 50,658     $ 24,769     $ 22,866  

Inventory Step-Up

     —        62       61       216       —        61  

Inventory Provision

     365       —        724       —        724       —   

Restructuring Charges

     29       —        367       —        30       337  

Product Retrofit Costs

     185       —        185       —        185       —   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Gross Profit

   $ 11,903     $ 12,289     $ 48,971     $ 50,874     $ 25,708     $ 23,264  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross Profit Margin

     30.2     32.7     31.6     33.5     32.3     31.0

Non-GAAP Gross Profit Margin

     31.7     32.9     32.5     33.6     33.5     31.5

Operating Expenses

   $ 11,270     $ 24,538     $ 46,428     $ 59,298     $ 23,426     $ 23,003  

MTEX-related Acquisition Expenses

     —        (254     (311     (1,204     —        (311

CFO Transition Costs

     —        —        —        (432     —        —   

Restructuring Charges

     (23     —        (990     —        (81     (910

Non-Recurring Legal Expenses

     (258     —        (715     —        (646     (69

Non-Recurring Proxy Costs

     (210     —        (738     —        (383     (355

Goodwill Impairment

     —        (13,403     (297     (13,403     (297     —   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Operating Expenses

   $ 10,779     $ 10,881     $ 43,377     $ 44,259     $ 22,019     $ 21,358  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating Income (Loss)

   $ 54     $ (12,311   $ 1,206     $ (8,640   $ 1,342     $ (137

MTEX-related Acquisition Expenses

     —        254       311       1,204       —        311  

CFO Transition Costs

     —        —        —        432       —        —   

Inventory Step-Up

     —        62       61       216       —        61  

Inventory Provision

     365       —        724       —        724       —   

Restructuring Charges

     52       —        1,357       —        110       1,247  

Product Retrofit Costs

     185       —        185       —        186       —   

Non-Recurring Legal Expenses

     258       —        715       —        646       69  

Non-Recurring Proxy Costs

     210       —        738       —        383       355  

Goodwill Impairment

     —        13,403       297       13,403       297       —   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Operating Income

   $ 1,124     $ 1,408     $ 5,594     $ 6,615     $ 3,688     $ 1,906  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating Income Margin

     0.1     (33.0 )%      0.8     (5.7 )%      1.7     (0.2 )% 

Non-GAAP Operating Income Margin

     3.0     3.8     3.7     4.4     4.8     2.6

Net Income (Loss)

   $ (1,134   $ (15,600   $ (2,376   $ (14,489   $ (756   $ (1,620

MTEX-related Acquisition Expenses(1)

     —        197       237       910       —        237  

CFO Transition Costs, net(1)

     —        (4     —        328       —        —   

Inventory Step-Up(1)

     —        50       49       161       —        49  

Inventory Provision(1)

     292       —        565       —        565       —   

Restructuring Charges(1)

     41       —        1,030       —        80       950  

Product Retrofit Costs(1)

     148       —        148       —        148       —   

Non-Recurring Legal Expenses(1)

     189       —        542       —        489       53  

Non-Recurring Proxy Costs(1)

     160       —        561       —        289       272  

Realized Fx(1)

     —        —        80       —        80       —   

Other (Income) and Expense(1)

     —        —        85       —        85       —   

Goodwill Impairment

     —        13,403       297       13,403       297       —   

Tax Provision Valuation Allowance

     —        2,373       —        2,373       —        —   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Net Income (Loss)

   $ (305   $ 419     $ 1,218     $ 2,686     $ 1,277     $ (59
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Diluted Earnings (Loss) Per Share

   $ (0.15   $ (2.07   $ (0.31   $ (1.93   $ (0.10   $ (0.21

MTEX-related Acquisition Expenses(1)

     —        0.03       0.03       0.12       —        0.03  

CFO Transition Costs, net(1)

     —        (0.00     —        0.04       —        —   

Inventory Step-Up(1)

     —        0.01       0.01       0.02       —        0.01  

Inventory Provision(1)

     0.04       —        0.07       —        0.07       —   

Restructuring Charges(1)

     0.01       —        0.14       —        0.01       0.13  

Product Retrofit Costs(1)

     0.02       —        0.02       —        0.02       —   

Non-Recurring Legal Expenses(1)

     0.02       —        0.07       —        0.06       0.01  

Non-Recurring Proxy Costs(1)

     0.02       —        0.07       —        0.04       0.04  

Realized Fx(1)

     —        —        0.01       —        0.01       —   

Other (Income) and Expense(1)

     —        —        0.01       —        0.01       —   

Goodwill Impairment(1)

     —        1.78       0.04       1.76       0.04       —   

Tax Provision Valuation Allowance

     —        0.31       —        0.31       —        —   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP Diluted Earnings (Loss) Per Share

   $ (0.04   $ 0.06     $ 0.16     $ 0.32     $ 0.16     $ (0.01
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(1) 

Net of taxes


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 16 of 19

 

ASTRONOVA INC.

Reconciliation of Net Income and Margin to Adjusted EBITDA and Margin

(Unaudited, $ in thousands)

 

     Three Months Ended  
     January 31,
2026
    January 31,
2025
 

Net Income (Loss)

   $ (1,134   $ (15,600

Interest Expense

     894       847  

Income Tax Expense (Benefit)

     346       2,342  

Depreciation & Amortization

     1,379       1,266  
  

 

 

   

 

 

 

EBITDA

   $ 1,485     $ (11,145

Share-Based Compensation

     752       219  

MTEX-related Acquisition Expenses

     —        259  

CFO Transition Costs

     —        (5

Inventory Step-Up

     —        62  

Inventory Provision

     365       —   

Restructuring Charges

     52       —   

Product Retrofit Costs

     185       —   

Non-Recurring Legal Expenses

     258       —   

Non-Recurring Proxy Costs

     210       —   

Goodwill Impairment

     —        13,403  
  

 

 

   

 

 

 

Adjusted EBITDA

   $ 3,306     $ 2,794  
  

 

 

   

 

 

 

Revenue

   $ 37,536     $ 37,361  

Net Income (Loss) Margin

     (3.0 )%      (41.8 )% 

Adjusted EBITDA Margin

     8.8     7.5

 

     Twelve Months Ended     2H Fiscal 2026 and 1H 2026  
     January 31,
2026
    January 31,
2025
    2H FY26     1H FY26  

Net Income (Loss)

   $ (2,376   $ (14,489   $ (757   $ (1,619

Interest Expense

     3,503       3,210       1,721       1,782  

Income Tax Expense (Benefit)

     (160     2,202       218       (378

Depreciation & Amortization

     4,804       4,780       2,234       2,570  
  

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA

   $ 5,771     $ (4,297   $ 3,418     $ 2,355  

Share-Based Compensation

     2,310       1,378       1,505       805  

MTEX-related Acquisition Expenses

     311       1,204       —        311  

CFO Transition Costs

     —        432       —        —   

Inventory Step-Up

     61       216       —        61  

Inventory Provision

     724       —        724       —   

Restructuring Charges

     1,357       —        110       1,247  

Product Retrofit Costs

     185       —        185       —   

Non-Recurring Legal Expenses

     715       —        646       69  

Non-Recurring Proxy Costs

     738       —        383       355  

Realized Fx

     100       —        100       —   

Other (Income) and Expense

     112       —        112       —   

Goodwill Impairment

     297       13,403       297       —   
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

   $ 12,681     $ 12,336     $ 7,478     $ 5,203  
  

 

 

   

 

 

   

 

 

   

 

 

 

Revenue

   $ 150,515     $ 151,283     $ 76,705     $ 73,810  

Net Income (Loss) Margin

     (1.6 )%      (9.6 )%      (1.0 )%      (2.2 )% 

Adjusted EBITDA Margin

     8.4     8.2     9.7     7.0


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 17 of 19

 

ASTRONOVA INC.

Reconciliation of Segment Gross Profit and Margin to Non-GAAP Gross Profit and Margin

(Unaudited, $ in thousands)

 

     Three Months Ended  
     January 31, 2026     January 31, 2025  
     Product
ID
    Aerospace     Total     Product
ID
    Aerospace     Total  

Segment Gross Profit

   $ 7,088     $ 4,237     $ 11,325     $ 8,237     $ 3,989     $ 12,226  

Inventory Step-Up

     —        —        —        62       —        62  

Inventory Provision

     54       311       365       —        —        —   

Product Retrofit Costs

     185       —        185       —        —        —   

Restructuring Charges

     29       —        29       —        —        —   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP - Segment Gross Profit

   $ 7,356     $ 4,548     $ 11,904     $ 8,299     $ 3,989     $ 12,288  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Revenue

   $ 26,330     $ 11,206     $ 37,536     $ 25,678     $ 11,683     $ 37,361  

Gross Profit Margin

     26.9     37.8     30.2     32.1     34.1     32.7

Non-GAAP Segment Gross Profit Margin

     27.9     40.6     31.7     32.3     34.1     32.9
     Twelve Months Ended  
     January 31, 2026     January 31, 2025  
     Product
ID
    Aerospace     Total     Product
ID
    Aerospace     Total  

Segment Gross Profit

   $ 29,837     $ 17,797     $ 47,634     $ 32,571     $ 18,087     $ 50,658  

Inventory Step-Up

     61       —        61       216       —        216  

Inventory Provision

     724       —        724       —        —        —   

Product Retrofit Costs

     185       —        185       —        —        —   

Restructuring Charges

     202       165       367       —        —        —   

Non-GAAP - Segment Gross Profit

   $ 31,009     $ 17,962     $ 48,971     $ 32,787     $ 18,087     $ 50,874  

Revenue

   $ 104,221     $ 46,294     $ 150,515     $ 102,345     $ 48,938     $ 151,283  

Gross Profit Margin

     28.6     38.4     31.6     31.8     37.0     33.5

Non-GAAP Segment Gross Profit Margin

     29.8     38.8     32.5     32.0     37.0     33.6


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 18 of 19

 

ASTRONOVA INC.

Reconciliation of Segment Operating Profit and Margin to Non-GAAP Operating Profit and Margin

(Unaudited, $ in thousands)

 

     Three Months Ended  
     January 31, 2026     January 31, 2025  
     Product
ID
    Aerospace     Total     Product
ID
    Aerospace     Total  

Segment Operating Income (Loss)

   $ (234   $ 2,337     $ 2,103     $ (13,075   $ 1,886     $ (11,189

MTEX-related Acquisition Expenses

     —        —        —        259       —        259  

Inventory Step-Up

     —        —        —        62       —        62  

Inventory Provision

     54       311       365       —        —        —   

Product Retrofit Costs

     185       —        185       —        —        —   

Restructuring Charges

     52       —        52       —        —        —   

Non-Recurring Legal Expenses

     (181     —        (181     —        —        —   

Goodwill Impairment

     —        —        —        13,403       —        13,403  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP - Segment Operating Income (Loss)

   $ (124   $ 2,648     $ 2,524     $ 649     $ 1,886     $ 2,535  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Revenue

   $ 26,330     $ 11,206     $ 37,536     $ 25,678     $ 11,683     $ 37,361  

Operating Margin

     (0.9 )%      20.9     5.6     (50.9 )%      16.1     (29.9 )% 

Non-GAAP Operating Margin

     (0.5 )%      23.6     6.7     2.5     16.1     6.8
     Twelve Months Ended  
     January 31, 2026     January 31, 2025  
     Product
ID
    Aerospace     Total     Product
ID
    Aerospace     Total  

Segment Operating Income (Loss)

   $ (471   $ 9,763     $ 9,292     $ (11,860   $ 9,088     $ (2,772

MTEX-related Acquisition Expenses

     311       —        311       1,204       —        1,204  

Inventory Step-Up

     61       —        61       216       —        216  

Inventory Provision

     724       —        724       —        —        —   

Product Retrofit Costs

     185       —        185       —        —        —   

Restructuring Charges

     483       171       654       —        —        —   

Non-Recurring Legal Expenses

     (48     —        (48     —        —        —   

Goodwill Impairment

     297       —        297       13,403       —        13,403  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP - Segment Operating Income

   $ 1,542     $ 9,934     $ 11,476     $ 2,963     $ 9,088     $ 12,051  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Revenue

   $ 104,221     $ 46,294     $ 150,515     $ 102,345     $ 48,938     $ 151,283  

Operating Margin

     (0.5 )%      21.1     6.2     (11.6 )%      18.6     (1.8 )% 

Non-GAAP Operating Margin

     1.5     21.5     7.6     2.9     18.6     8.0


AstroNova Reports Fourth-Quarter and Full-Year Fiscal 2026 Financial Results

April 13, 2026

Page 19 of 19

 

ASTRONOVA INC.

Reconciliation of Segment and Consolidated Net Income to Adjusted EBITDA (Past Quarters and Years)

(Unaudited, $ in thousands)

 

         2024     Q1 25     Q2 25     Q3 25     Q4 25     FY25     Q1 26     Q2 26     Q3 26     Q4 26     FY26  
LOGO                                                                       
   Operating Income   $ 8,240     $ 1,108     $ 3,302     $ 2,792     $ 1,886     $ 9,088     $ 1,980     $ 1,666     $ 3,780     $ 2,338     $ 9,763  
   Other     —        —        —        —        —        —        —        —        —        —        —   
   Interest expense     —        —        —        —        —        —        —        —        —        —        —   
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Profit Before Tax   $ 8,240       1,108       3,302       2,792       1,886     $ 9,088       1,980       1,666       3,780       2,338     $ 9,763  
   Tax     —        —        —        —        —        —        —        —        —        —        —   
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Net Income   $ 8,240       1,108       3,302       2,792       1,886     $ 9,088       1,980       1,666       3,780       2,338     $ 9,763  
   Depreciation & Amortization     1,873       374       378       365       365       1,482       373       368       363       360       1,464  
   Share-Based Compensation     126       37       39       36       29       140       43       46       80       94       263  
   Inventory Provision     —        —        —        —        —        —        —        —        (311     311       —   
   Restructuring Charges     —        —        —        —        —        —        170       1       —        —        171  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Adjusted EBITDA   $ 10,239     $ 1,519     $ 3,719     $ 3,193     $ 2,279     $ 10,710     $ 2,566     $ 2,081     $ 3,911     $ 3,104     $ 11,662  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Revenue   $ 44,045     $ 9,776     $ 13,374     $ 14,105     $ 11,683     $ 48,938     $ 11,419     $ 11,348     $ 12,320     $ 11,206     $ 46,294  
   Adjusted EBITDA Margin     23.2     15.5     27.8     22.6     19.5     21.9     22.5     18.3     31.7     27.7     25.2
       2024     Q1 25     Q2 25     Q3 25     Q4 25     FY25     Q1 26     Q2 26     Q3 26     Q4 26     FY26  

LOGO

 

                                                                      
   Operating Income   $ 5,325     $ 1,449     $ (121   $ (113   $ (13,075   $ (11,860   $ 259     $ (192   $ (304   $ (234   $ (471
   Other     —        —        —        —        —        —        —        —        —        —        —   
   Interest expense     —        —        —        —        —        —        —        —        —        —        —   
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Profit Before Tax   $ 5,325       1,449       (121     (113     (13,075   $ (11,860     259       (192     (304     (234   $ (471
   Tax     —        —        —        —        —        —        —        —        —        —        —   
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Net Income   $ 5,325       1,449       (121     (113     (13,075   $ (11,860     259       (192     (304     (234   $ (471
   Interest expense     —        —        —        —        —        —        —        —        —        —        —   
   Tax     —        —        —        —        —        —        —        —        —        —        —   
   Depreciation & Amortization     2,378       532       921       929       896       3,279       913       909       489       1,013       3,322  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Share-Based Compensation     317       64       74       94       75       308       (7     86       88       207       373  
   MTEX-related Acquisition Expenses     —        —        625       325       254       1,204       337       (26     —        —        311  
   Inventory Step-Up     —        —        120       34       62       216       61       —        —        —        61  
   Inventory Provision     —        —        —        —        —        —        —        —        670       54       724  
   Restructuring Charges     2,494       —        —        —        —        —        339       94       (2     52       483  
   Product Retrofit Costs     642       —        —        —        —        —        —        —        —        185       185  
   Non-Recurring Legal Expenses     —        —        —        —        —        —        —        —        134       (182     (48
   Goodwill Impairment     —        —        —        —        13,403       13,403       —        —        297       —        297  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Adjusted EBITDA     11,156       2,046       1,619       1,269       1,615       6,550       1,902       870       1,371       1,095       5,238  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Revenue   $ 104,041     $ 23,185     $ 27,165     $ 26,317     $ 25,679     $ 102,345     $ 26,289     $ 24,754     $ 26,849     $ 26,330     $ 104,221  
   Adjusted EBITDA Margin     10.7     8.8     6.0     4.8     6.3     6.4     7.2     3.5     5.1     4.2     5.0
         2024     Q1 25     Q2 25     Q3 25     Q4 25     FY25     Q1 26     Q2 26     Q3 26     Q4 26     FY26  

LOGO

 

                                                                      
   Operating Income   $ (4,768   $ (1,211   $ (2,120   $ (1,416   $ (1,122   $ (5,869   $ (1,668   $ (2,181   $ (2,187   $ (2,050   $ (8,087
   Other     26       118       173       46       100       437       (24     104       210       (51     239  
   Interest expense     2,697       482       938       944       847       3,210       897       885       827       894       3,503  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Profit Before Tax   $ (7,491     (1,811     (3,231     (2,406     (2,069   $ (9,516     (2,541     (3,170     (3,224     (2,893   $ (11,829
   Tax     1,379       (434     261       34       2,342       2,203       75       (454     (128     346       (161
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Net Income   $ (8,870     (1,377     (3,492     (2,440     (4,411   $ (11,719     (2,616     (2,716     (3,096     (3,239   $ (11,668
   Interest expense     2,697       482       938       944       847       3,210       897       885       827       894       3,503  
   Tax     1,379       (434     261       36       2,342       2,205       75       (454     (128     346       (161
   Depreciation & Amortization     15       4       4       6       4       19       4       4       5       5       18  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   EBITDA   $ (4,779     (1,324     (2,289     (1,454     (1,218   $ (6,285     (1,640     (2,282     (2,392     (1,994   $ (8,308
   Share-Based Compensation     903       223       368       222       116       929       270       367       586       449       1,673  
   CFO Transition Costs     —        —        432       —        —        432       —        —        —        —        —   
   Restructuring Charges     82       —        —        —        —        —        49       595       60       —        703  
   Non-Recurring Legal Expenses     —        —        —        —        —        —        —        69       254       440       763  
   Non-Recurring Proxy Costs     —        —        —        —        —        —        —        355       172       210       738  
   Realized Fx     —        —        —        —        —        —        —        —        100       —        100  
   Other (Income) and Expense     —        —        —        —        —        —        —        —        112       —        112  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Adjusted EBITDA   $ (3,794   $ (1,101   $ (1,489   $ (1,232   $ (1,102   $ (4,924   $ (1,321   $ (896   $ (1,108   $ (895   $ (4,220
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
         2024     Q1 25     Q2 25     Q3 25     Q4 25     FY25     Q1 26     Q2 26     Q3 26     Q4 26     FY26  

LOGO

 

                                                                      
   Operating Income   $ 8,796     $ 1,346     $ 1,061     $ 1,263     $ (12,311   $ (8,641   $ 571     $ (708   $ 1,288     $ 55     $ 1,207  
   Other     26       118       173       46       100       437       (24     104       210       (51     239  
   Interest expense     2,697       482       938       944       847       3,210       897       885       827       894       3,503  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Profit Before Tax   $ 6,073       746       (50     273       (13,258   $ (12,288     (302     (1,697     251       (789   $ (2,536
   Tax     1,379       (434     261       34       2,342       2,202       75       (454     (128     346       (161
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Net Income   $ 4,694       1,180       (311     239       (15,600   $ (14,490     (377     (1,243     379       (1,134   $ (2,374
   Interest expense     2,697       482       938       944       847       3,210       897       885       827       894       3,503  
   Tax     1,379       (434     261       36       2,342       2,202       75       (454     (128     346       (161
   Depreciation & Amortization     4,266       911       1,304       1,300       1,266       4,780       1,290       1,280       856       1,379       4,805  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   EBITDA   $ 13,036       2,139       2,191       2,519       (11,146   $ (4,297     1,885       469       1,934       1,485     $ 5,773  
   Share-Based Compensation     1,347       325       481       352       219       1,378       306       499       754       751       2,310  
   MTEX-related Acquisition Expenses     —        —        625       325       254       1,204       337       (26     —        —        311  
   CFO Transition Costs     —        —        432       —        —        432       —        —        —        —        —   
   Inventory Step-Up     —        —        120       34       62       216       61       —        —        —        61  
   Inventory Provision     —        —        —        —        —        —        —        —        359       365       724  
   Restructuring Charges     2,576       —        —        —        —        —        558       689       59       52       1,357  
   Product Retrofit Costs     642       —        —        —        —        —        —        —        —        185       185  
   Non-Recurring Legal Expenses     —        —        —        —        —        —        —        69       387       258       715  
   Non-Recurring Proxy Costs     —        —        —        —        —        —        —        355       172       210       738  
   Realized Fx     —        —        —        —        —        —        —        —        100       —        100  
   Other (Income) and Expense     —        —        —        —        —        —        —        —        112       —        112  
   Goodwill Impairment     —        —        —        —        13,403       13,403       —        —        297       —        297  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Adjusted EBITDA   $ 17,601     $ 2,463     $ 3,849     $ 3,230     $ 2,793     $ 12,336     $ 3,146     $ 2,056     $ 4,175     $ 3,306     $ 12,681  
    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   Revenue   $ 148,086     $ 32,961     $ 40,539     $ 40,422     $ 37,361     $ 151,283     $ 37,708     $ 36,102     $ 39,169     $ 37,536     $ 150,515  
   Adjusted EBITDA Margin     11.9     7.5     9.5     8.0     7.5     8.2     8.3     5.7     10.7     8.8     8.4

FAQ

How did AstroNova (ALOT) perform in Q4 fiscal 2026?

AstroNova’s Q4 fiscal 2026 revenue was $37.5 million, essentially flat year over year. Gross margin fell to 30.2%, and the company reported a net loss of $1.1 million, or $(0.15) per share, but results improved sharply versus the prior year’s impairment-impacted quarter.

What were AstroNova’s full-year fiscal 2026 results?

For fiscal 2026, AstroNova generated $150.5 million in revenue and a net loss of $2.4 million, compared with a $14.5 million loss in fiscal 2025. Adjusted EBITDA increased to $12.7 million with an 8.4% margin, indicating stronger underlying operating performance.

How did AstroNova’s Product Identification segment perform in fiscal 2026?

The Product Identification segment delivered $104.2 million of revenue in fiscal 2026, up from $102.3 million the prior year. Aftermarket revenue remained strong, representing about 80% of segment sales, and segment non‑GAAP operating loss narrowed to $0.5 million, or 1.5% of revenue.

What were the key results for AstroNova’s Aerospace segment?

AstroNova’s Aerospace segment recorded fiscal 2026 revenue of $46.3 million, slightly below $48.9 million in fiscal 2025. Despite lower sales, Aerospace segment operating profit increased to $9.8 million, with operating margin improving to 21.1% on favorable product mix and strong bookings.

How is AstroNova’s balance sheet and cash flow position at year-end fiscal 2026?

At January 31, 2026, AstroNova held $4.1 million of cash and had $37.6 million of debt, down from $46.7 million a year earlier. Fiscal 2026 operating cash flow was $11.7 million, reflecting improved working capital, particularly lower inventories.

What outlook did AstroNova (ALOT) provide for fiscal 2027?

For fiscal 2027, AstroNova expects mid‑single‑digit revenue growth and expanded adjusted EBITDA margin. Management also highlighted that a major Aerospace royalty obligation expiring in the third quarter should add about $2 million to annual gross profit beginning in the fourth quarter.

What is the significance of the royalty obligation expiring for AstroNova?

A major royalty obligation in the Aerospace business is scheduled to expire in the third quarter of fiscal 2027. The company estimates this will improve annual gross profit by roughly $2 million, beginning in Q4 fiscal 2027, supporting future margin expansion.

Filing Exhibits & Attachments

4 documents